An agent that activates natural killer cells and is useful in renal cell carcinoma is:
(Ref: Katzung 10/e p906) Recombinant IL-2 (aldesleukin) is used for the treatment of malignatn melanoma and renal cell carcinoma.
Aldesleukin
Etanercept
Leflunomide
Thalidomide
Other topics and Adverse effects